Is Heron Therapeutics Inc (HRTX) a good stock to buy now?

Heron Therapeutics Inc (NASDAQ: HRTX) is -30.00% lower on its value in year-to-date trading and has touched a low of $0.72 and a high of $3.93 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The HRTX stock was last observed hovering at around $1.24 in the last trading session, with the day’s loss setting it -0.05%.

Currently trading at $1.19, the stock is -29.27% and -34.72% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.5 million and changing -4.03% at the moment leaves the stock -53.45% off its SMA200. HRTX registered 38.37% gain for a year compared to 6-month loss of -62.81%. The firm has a 50-day simple moving average (SMA 50) of $1.8228 and a 200-day simple moving average (SMA200) of $2.5566.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

The stock witnessed a -34.62% gain in the last 1 month and extending the period to 3 months gives it a -39.90%, and is -32.00% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 18.23% over the week and 8.61% over the month.

Heron Therapeutics Inc (HRTX) has around 126 employees, a market worth around $173.20M and $137.74M in sales. Profit margin for the company is -20.30%. Distance from 52-week low is 65.28% and -69.72% from its 52-week high. The company has generated returns on investments over the last 12 months (-20.72%).

with sales reaching $37.37M over the same period.The EPS is expected to grow by 83.75% this year, but quarterly earnings will post 18.76% year-over-year. Quarterly sales are estimated to grow 9.15% in year-over-year returns.

Heron Therapeutics Inc (HRTX) Top Institutional Holders

219.0 institutions hold shares in Heron Therapeutics Inc (HRTX), with institutional investors hold 82.18% of the company’s shares. The shares outstanding are 150.29M, and float is at 144.08M with Short Float at 20.00%. Institutions hold 81.60% of the Float.

The top institutional shareholder in the company is RUBRIC CAPITAL MANAGEMENT LP with over 26.71 million shares valued at $93.5 million. The investor’s holdings represent 17.6678% of the HRTX Shares outstanding. As of 2024-06-30, the second largest holder is VANGUARD GROUP INC with 8.62 million shares valued at $30.16 million to account for 5.6984 of the shares outstanding. The other top investors are BLACKROCK INC. which holds 8.33 million shares representing 5.5062% and valued at over $29.14 million, while ADAGE CAPITAL PARTNERS GP, L.L.C. holds 5.0265 of the shares totaling 7.6 million with a market value of $26.6 million.